Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
Vrishali S. Salian, Jessica Wright, Peter T. Vedell, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 3, pp. 754-771
Closed Access | Times Cited: 300

Showing 1-25 of 300 citing articles:

The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19
Christoph Schultheiß, Edith Willscher, Lisa Paschold, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 6, pp. 100663-100663
Open Access | Times Cited: 314
Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics
Shuo Wang, Biyu Lei, E Zhang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 1757-1781
Open Access | Times Cited: 98
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
Mengxin Zhang, Ying Liang, Dongsheng Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 2, pp. 889-900
Open Access | Times Cited: 60
PWM2Vec: An Efficient Embedding Approach for Viral Host Specification from Coronavirus Spike Sequences
Sarwan Ali, Babatunde Bello, Prakash Chourasia, et al.
Biology (2022) Vol. 11, Iss. 3, pp. 418-418
Open Access | Times Cited: 44
Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms
Ameneh Jafari, Fahima Danesh Pouya, Zahra Niknam, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 6, pp. 4943-4957
Open Access | Times Cited: 41
Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study
Abdisa Tufa, Tewodros Haile Gebremariam, Tsegahun Manyazewal, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge
Hongwei Li, Xue Li, Qian Wu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 38
The Role of Vitamin C in Human Immunity and Its Treatment Potential Against COVID-19: A Review Article
Austin Moore, Deepesh Khanna
Cureus (2023)
Open Access | Times Cited: 26
The Role of Cyclodextrins in COVID-19 Therapy—A Literature Review
Beatriz C. Almeida, Cátia Domingues, Filipa Mascarenhas‐Melo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2974-2974
Open Access | Times Cited: 22
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 545-545
Open Access | Times Cited: 22
Engineering surgical face masks with photothermal and photodynamic plasmonic nanostructures for enhancing filtration and on-demand pathogen eradication
Mohammad Ali Haghighat Bayan, Chiara Rinoldi, Daniel Rybak, et al.
Biomaterials Science (2024) Vol. 12, Iss. 4, pp. 949-963
Open Access | Times Cited: 13
Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view
Julia Martı́n, Noelia Tena, Agustín G. Asuero
Microchemical Journal (2021) Vol. 167, pp. 106305-106305
Open Access | Times Cited: 47
Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
Bo He, Zhao Huang, Canhua Huang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2022) Vol. 16, Iss. 6
Closed Access | Times Cited: 36
Predicting potential microbe–disease associations based on multi-source features and deep learning
Liugen Wang, Yan Wang, Chenxu Xuan, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 4
Closed Access | Times Cited: 17
Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity
Carla Guijarro-Real, Mariola Plazas, Adrián Rodríguez‐Burruezo, et al.
Foods (2021) Vol. 10, Iss. 7, pp. 1503-1503
Open Access | Times Cited: 38
Current status of traditional Chinese medicine for the treatment of COVID-19 in China
Liang Chu, Fang Huang, Mengdan Zhang, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 38
Favipiravir-Based Ionic Liquids as Potent Antiviral Drugs for Oral Delivery: Synthesis, Solubility, and Pharmacokinetic Evaluation
Rahman Md Moshikur, Md. Korban Ali, Rie Wakabayashi, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 8, pp. 3108-3115
Closed Access | Times Cited: 35
New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches
Kexin Jia, Yijie Li, Tiegang Liu, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 2, pp. 157-168
Open Access | Times Cited: 14
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2
Prabhat Kumar Purbey, Koushik Roy, Sandeep Gupta, et al.
Molecular Immunology (2023) Vol. 156, pp. 111-126
Open Access | Times Cited: 13
An overview of SARS‐CoV2 natural infections in companion animals: A systematic review of the current evidence
Zahra Heydarifard, Ardalan Maleki Chegeni, Fatemeh Heydarifard, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 5
Research advances in microfluidic collection and detection of virus, bacterial, and fungal bioaerosols
Xin-yue Zhou, Xin Liu, Haiyang Zhao, et al.
Microchimica Acta (2024) Vol. 191, Iss. 3
Closed Access | Times Cited: 5
Isolation and Preliminary Characterization of a Novel scFv against SARS-CoV-2 : an Experimental and Computational Analysis
Samaneh Jahandar-Lashaki, Safar Farajnia, Effat Alizadeh, et al.
Avicenna Journal of Medical Biotechnology (2025)
Closed Access
The role of candidate genetic polymorphisms in covid-19 susceptibility and outcomes
Anthony Yazbeck, Reem Akika, Zainab Awada, et al.
BMC Medical Genomics (2025) Vol. 18, Iss. 1
Open Access
Health Literacy and Acceptance of COVID-19 Preventive Measures and Vaccination in the European Union: A Scoping Review
Evridiki Vasileia, George Koulierakis, Theodoros Fouskas, et al.
HLRP Health Literacy Research and Practice (2025) Vol. 9, Iss. 1
Open Access
PRODUCTION OF POTENT NEUTRALIZING POLYCLONAL ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME-CORONAVIRUS-2 (SARS-CoV-2) IN RABBITS, IMMUNIZED WITH RECEPTOR BINDING DOMAIN HEPATITIS B SURFACE ANTIGEN CONJUGATE PROTEIN AND WHOLE INACTIVATED SARS-CoV-2 (MT416726): A COMPARATIVE STUDY
D. S. Yadav, Nandkumar Kadam, Sankunny Mohan Karuppayil, et al.
International Journal of Applied Pharmaceutics (2025), pp. 314-320
Open Access
Page 1 - Next Page

Scroll to top